How has been the historical performance of QMS Medical?

Answer:The historical performance of QMS Medical shows significant growth in various financial metrics from March 2024 to March 2025.

Breakdown:
In the fiscal year ending March 2025, QMS Medical reported net sales of 156.01 Cr, an increase from 122.13 Cr in the previous year. Total operating income also rose to 156.01 Cr from 122.13 Cr, while total expenditure, excluding depreciation, increased to 130.60 Cr from 103.78 Cr. The operating profit (PBDIT) grew to 27.13 Cr from 18.81 Cr, reflecting an improved operating profit margin of 16.29%, up from 15.02%. Profit before tax increased to 18.66 Cr from 12.24 Cr, leading to a profit after tax of 13.70 Cr, compared to 9.00 Cr in the prior year. The earnings per share rose to 6.7 from 5.04, and the PAT margin improved to 8.78% from 7.37%. On the balance sheet, total liabilities increased to 189.79 Cr from 135.32 Cr, with total assets also rising to 189.79 Cr from 135.32 Cr. The company experienced a cash flow from operating activities of 20.00 Cr, a significant increase from 1.00 Cr in the previous year, while cash flow from investing activities worsened to -45.00 Cr from -2.00 Cr. Overall, QMS Medical demonstrated strong growth in sales, profits, and operational efficiency over the year.